Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of ...
Investment led by healthcare-focused institutional investor with participation from SymBiosis; founding investor Kensington Capital Holdings; Clene’s Chairman of the Board of Directors, Chief Executive Officer and Chief Scientific Officer and Founder; …